Role of the metabolic enzyme fumarate hydratase in aged haematopoiesis and malignant transformation
dc.contributor.advisor
Kranc, Kamil
en
dc.contributor.advisor
Forrester, Lesley
en
dc.contributor.author
Panagopoulou, Theoni Ioanna
en
dc.contributor.sponsor
Medical Research Council (MRC)
en
dc.date.accessioned
2017-09-22T14:33:57Z
dc.date.available
2017-09-22T14:33:57Z
dc.date.issued
2017-07-08
dc.description.abstract
The finely tuned regulation of haematopoiesis is crucial in order to maintain life-long
haematopoiesis. The disruption of the balance among cell fates, can lead to
malignant transformation. It has become increasingly evident that the metabolic
regulation haematopoietic stem cells is critical for stem cell fate decisions.
Haematopoietic stem cells reside in a hypoxic microenvironment within the bone
marrow and are thought to mainly utilize glycolysis rather than oxidative
phosphorylation in order to maintain their pool. However recent evidence suggests
that oxidative phosphorylation is critical for quiescent HSCs and in several cases, for
leukaemic stem cells (LSCs).
One of the key parts of mitochondrial respiration is the tricarboxylic cycle (TCA),
providing co-factors for its efficient activity. The TCA functions by catalysing the
oxidation of pyruvate via key enzymatic activities.
A key component of the TCA cycle is fumarate hydratase (Fh1) which catalyses the
hydration of fumarate into malate within the mitochondria, but also catalyses the
same reaction in the cytoplasm. FH is a tumour suppressor in human lyomeioma and
renal kidney cancer (HLRCC). Previous work conducted by our team has shown that
Fh1 is essential for foetal and adult haematopoiesis, as Fh1 deletion within the
haematopoietic system is embryonic lethal. Furthermore, conditional deletion of Fh1
in donor cells of the Mx1-Cre system that were injected in lethally irradiated
recipients, resulted in the complete reduction of their chimerism in the peripheral
blood of recipient mice. Mechanistically, these phenotypes were mostly associated
with supra-physiological levels of fumarate as a result of Fh1 deletion. Interestingly,
by employing mice that ubiquitously express the human cytosolic isoform of FH
(FHCyt, which lacks the mitochondrial targeting sequence and therefore is excluded
from the mitochondria), we rescued the embryonic lethality that Fh1 causes, and
reduced the levels of fumarate. Importantly, although FHCyt expression restored
fumarate-associated lethality, it did not restore the mitochondrial defects, allowing us
to study the importance of genetically intact TCA in the context of haematopoiesis.
Here I investigated the impact that a genetic truncation of the TCA cycle (as a result
of the lack of the mitochondrial isoform of Fh1) has on leukaemic transformation
and on aged haematopoiesis. Fh1fl/fl; FHCyt; Vav-iCre mice of approximately 60
weeks old displayed and expansion in the pool of early stem and progenitor
compartment (Lin- Sca-1+ c-Kit+), as well as in the early progenitors HPC-1 (LSK
CD48+ CD150-) and HPC-2 (LSK CD48+ CD150+). Furthermore, the mice exhibited
a drastic depletion of B cells (CD19+ B220+) and an expansion in the frequency of
the myeloid compartment (Mac-1+ Gr1+).
In order to assess the importance of the TCA cycle in malignant transformation, I
isolated stem and progenitor cells from Fh1fl/fl; FHCyt; Vav-iCre (and control (Fh1fl/fl;
FHCyt Vav-iCre negative or Fh1fl/fl Vav-iCre negative)) E 14.5 day old embryos and
infected them with retroviruses expressing Meis1 and Hoxa9, and generated pre-leukaemic
cells (pre-LCs). Genetically intact TCA was required for the efficient
generation of leukaemia-initiating cells (LICs), as injection of pre-LCs lacking
mitochondrial Fh1 into sub-lethally irradiated recipient mice, resulted in 76 % of
leukaemia-free mice while injection of control pre-LCs resulted in 25 % of
leukaemia-free mice. However, the genetic perturbation of the TCA did not exert and
effect on the long-term self-renewal capacity of LICs. Inducible deletion of
mitochondrial Fh1 in established LICs of the Mx1-Cre background using poly (I:C)
did not affect their ability to generate AML in primary and secondary recipient mice.
These data indicate that genetically intact TCA is required for the efficient
generation of LICs in vivo but is dispensable for their long-term self-renewal
capacity, highlighting the metabolic rewiring that occurs at different stages of
leukaemic transformation.
In an effort to understand whether, similarly to HLRCC, Fh1 plays a tumour-suppressive
role in malignant haematopoiesis, I isolated LSK cells from the foetal
liver of E 14.5 old embryos lacking both isoforms of Fh1. Fh1fl/fl; Vav-iCre cells
transduced with Meis1/Hoxa9 or MLL-AF9, MLL-ENL, AML-ETO (chromosomal
translocations involved in AML development) -expressing retroviruses, failed to
generate colonies in methylcellulose, indicating that stem and progenitor cells require
Fh1 to undergo in vitro transformation by these oncogenes. Furthermore, acute
deletion of Fh1 (via the use of lentivirally-expressed Cre) in pre-LCs generated using
the Meis1/Hoxa9 retroviruses, rendered them unable to generate colonies in
methylcellulose, indicating that Fh1 is required for the self-renewal capacity of pre-
LCs in vitro. Similarly, when LICs (Fh1fl/fl; Vav-iCre negative) isolated from primary
recipient mice were infected with Cre to induce deletion of Fh1, they were unable to
generate colonies indicating that Fh1 is required for the self-renewal capacity of
LICs in vitro. Finally, in order to identify whether Fh1 is important for LIC self-renewal
in vivo I generated Fh1fl/fl; Mx1-Cre pre-LCs by infecting stem and
progenitor cells of E 14.5 embryos with Meis1/Hoxa9 retroviruses, and injected them
into sub-lethally irradiated mice. After the mice developed AML, I induced the
deletion of Fh1, by injecting the mice with poly (I:C). Interestingly, the percentage
of LICs in the peripheral blood of recipient mice was drastically decreased, leaving
recipient mice leukaemia-free for the remaining time they were monitored.
Surprisingly however, approximately 50 % of the recipient mice exhibited a drastic
increase in LIC chimerism after two weeks post poly (I:C). Assessment of LICs
isolated from recipient mice indicated that Fh1 was fully deleted. These data indicate
that while in some cases Fh1 is required for LIC self-renewal in vivo, in other cases it
is dispensable. Therefore, the tumour-suppressive roles of Fh1 are likely tissue-specific
and do not extend to haematopoietic cells.
Overall, this study agrees with published work supporting the notion that intact
mitochondrial respiration is important (in varying degrees), in both the contexts of
normal and malignant haematopoiesis.
en
dc.identifier.uri
http://hdl.handle.net/1842/23584
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Guitart A, Panagopoulou T, Vukovic M, Sepulveda C, Sas Z, Gonzalez MV, Allen L, Armesilla-Diaz A,Edwards-Hicks J, Wills J, Easterbrook A, Corman D, Pollard P, Morton N, Carter R, Finch A, Kranc KR. Fumarate hydratase is a critical metabolic regulator of haematopoietic stem cell functions. Journal of Experimental Medicine.
en
dc.relation.hasversion
Vukovic M, Subramani C, Sepulveda C, Guitart A, Allen L, Panagopoulou T, Holyoake T, Ratcliffe PJ, Kranc KR. Adult haematopoietic stem cells lacking Hif-1α self-renew normally. Blood. 2016; 127, 2841-2846.
en
dc.relation.hasversion
Vukovic M, Guitart AV, Sepulveda C, Villacreces A, O'Duibhir E, Panagopoulou T, Ivens A, Menendez-Gonzalez J, Iglesias JM, Allen L, Glykofrydis F, Subramani C, Armesilla-Diaz A, Post AE, Schaak K, Gezer D, So CW, Holyoake TL, Wood A, O'Carroll D, Ratcliffe PJ, Kranc KR. Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance. J Exp Med. 2015 Dec14;212(13):2223-34.
en
dc.subject
fumarate hydratase
en
dc.subject
acute myeloid leukaemia
en
dc.title
Role of the metabolic enzyme fumarate hydratase in aged haematopoiesis and malignant transformation
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en
This item appears in the following Collection(s)

